The aim of the study was to assess the role of the complement system in Sta
phylococcus aureus arthritis and septicaemia. The murine model of haematoge
nously acquired septic arthritis was used, injecting intravenously toxic sh
ock syndrome toxin-1 (TSST-1), producing S. aureus LS-1. Complement was dep
leted using cobra venom factor (CVF). Evaluation of arthritis was performed
clinically and histopathologically. In addition, the effect of complement
depletion on the phagocytic activity of leucocytes was assessed in vivo and
in vitro. Six days after inoculation of S. aureus the prevalence of arthri
tis in decomplemented mice was three-fold higher than that in controls (91%
versus 25%). The clinical severity of arthritis at the end of the experime
nt, expressed as arthritic index, was 7.3 and 1.9, respectively. These find
ings were confirmed by histological index of synovitis as well as of cartil
age and/or bone destruction being significantly higher in decomplemented mi
ce than in controls (9.8 +/- 1.7 versus 4.9 +/- 1.2, P < 0.05; and 7.9 +/-
1.7 versus 3.0 +/- 0.9, P < 0.05, respectively). Also, the septicaemia-indu
ced mortality was clearly higher in decomplemented mice compared with the c
ontrols. CVF treatment significantly reduced in vivo polymorphonuclear cell
-dependent inflammation induced by subcutaneous injection of olive oil and
mirroring the capacity of polymorphonuclear cells (PMNC) to migrate and/or
extravasate. Besides, the decomplementation procedure significantly impaire
d phagocytic activity of peripheral blood leucocytes in vitro, since the nu
mber of phagocytes being able to ingest bacteria decreased by 50% when the
cells were maintained in decomplemented serum compared with those in intact
serum. The conclusion is that complement depletion aggravates the clinical
course of S. aureus arthritis and septicaemia, possibly by a combination o
f decreased migration/extravasation of PMNC and an impairment of phagocytos
is.